SEC Form 4 · accession 0001209191-15-079319
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David F Hale
Officer — Chairman · Director
Period of report
Nov 9, 2015
Accepted (ET)
Nov 10, 2015 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 9, 2015 | M | 10,204 | — | A | 34,694 | D | |
| Common StockF1 | Nov 9, 2015 | M | 53,662 | — | A | 88,356 | D | |
| Common Stock | holding | — | — | — | 94,570 | I | By LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2,F3 | — | Nov 9, 2015 | M | 10,204 | D | — | — | Common Stock | 10,204 | 0 | D |
| Restricted Stock UnitsF1,F2,F3 | — | Nov 9, 2015 | M | 53,662 | D | — | — | Common Stock | 53,662 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
- F2The restricted stock units are fully vested.
- F3The restricted stock units are fully vested.
Remarks
This Form 4 is being filed to report the issuance of shares of the Issuer's Common Stock underlying two Restricted Stock Units (RSU) that were reported in Table II of the Reporting Person's Form 3. The share amount of the 53,662 RSU was to be fixed at a share number equal to 1.5% of the Issuer's outstanding stock on a fully diluted basis, determined as of immediately before the closing of the Issuer's initial public offering (IPO). Both of the RSU's reported herein fully vested upon the closing of the Issuer's IPO, and the shares of the Issuer's Common Stock underlying the RSU's are now being issued.